山東誠匯雙達(dá)藥業(yè)有限公司誠摯邀請(qǐng)您蒞臨2025日本東京制藥原料展覽會(huì)(CPHI Japan)，與我們?cè)?strong>6A-07展位共話合作機(jī)遇，探討行業(yè)前沿趨勢(shì)!
展會(huì)速覽
時(shí)間：2025年4月9日-11日
地點(diǎn)：日本東京有明國際會(huì)展中心
規(guī)模：全球50余國逾800家展商參展，預(yù)計(jì)吸引超3萬名專業(yè)觀眾
聚焦領(lǐng)域：原料藥、生物試劑、天然提取物、制藥技術(shù)及法規(guī)動(dòng)態(tài)
作為亞洲制藥行業(yè)標(biāo)桿展會(huì)，CPHI Japan匯聚全球頂尖企業(yè)，是鏈接技術(shù)革新、市場(chǎng)洞察與供應(yīng)鏈合作的核心平臺(tái)。日本憑借領(lǐng)先的研發(fā)實(shí)力與嚴(yán)苛質(zhì)量標(biāo)準(zhǔn)，持續(xù)引領(lǐng)制藥行業(yè)創(chuàng)新方向。
產(chǎn)品展示
我們將攜局麻類、抗病毒類、心腦血管類、抗腫瘤類、獸藥原料等核心產(chǎn)品亮相，展現(xiàn)高純度原料藥與中間體的研發(fā)實(shí)力。（部分產(chǎn)品展示如下，如需了解更多產(chǎn)品請(qǐng)聯(lián)系我們）
*Vonoprazan Fumarate
1260141-27-2
*Dapagliflozin propanediol monohydrate
960404-48-2
Sugammadex sodium
343306-79-6
*Baloxavir Marboxil
1985606-14-1
*Ruxolitinib Phosphate
941678-49-5
*Upadacitinib
1310726-60-3
*Fexuprazan HCI
1902954-87-3
Ozagrel sodium
189224-26-8
Ropivacaine HCI
132112-35-7
Bupivacaine HCI
73360-54-0
*Oclacitinib maleate
1208319-27-0
獸藥中間體
Veterinary intermediates
4-acetyl-2-methylbenzoic acid
55860-35-0
2-AMino-N-(2,2,2-trifluoroethyl)acetaMide hydrochloride
1171331-39-7
3',5'-dichloro-2,2,2-trifluoroacetophenone
130336-16-2
4-acetyl-1-naphthoic acid
131986-05-5
1-[3-Chloro-5-trifluoromethylphenyl]-2,2,2-trifluoroethanone
1125812-58-9
4-(5-(3-chloro-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-1-naphthoic acid
1308362-48-2
Trans-4-aminocyclohexanecarboxylic acid hydrochloride
27960-59-4
N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide maleate
1640292-55-2
瑪巴洛沙韋中間體
Baloxavir Marboxil Intermediates
(R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione
1985607-70-2
3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid
119736-16-2
7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol
1985607-83-7
富馬酸伏諾拉生中間體
Vonoprazan Fumarate Intermediates
5-(2-fluorophenyl)-1H-Pyrrole-3-carboxaldehyde
881674-56-2
Pyridine-3-sulfonyl chloride
16133-25-8
依度沙班中間體
Edoxaban Intermediates
(1S,4S,5S)-4-Bromo-6-oxabicyclo[3.2.1]octan-7-one
139893-81-5
tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate
1210348-34-7
tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate
365998-36-3
2-bromo-5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine;4-methylbenzenesulfonic acid
852291-42-0
*All our products are not offered in countries where valid patents exist. All responsibility with repect to third parties patent rights in specific countries lies exclusively with the buyers.
*The advanced intermediates of all above APIs are available
期待與您同行
此次參展，我們期待與全球伙伴深化合作，共同應(yīng)對(duì)行業(yè)挑戰(zhàn)，探索新興市場(chǎng)機(jī)遇。歡迎您蒞臨6A-07展位，通過CPHI Japan這一全球舞臺(tái)，誠匯雙達(dá)愿與您攜手，共筑制藥原料行業(yè)新未來!
聯(lián)系我們
電話：+86-531-58897029/7070
郵箱：market@chsdpharma.com
網(wǎng)站：www.chsdpharma.com
2025年4月，東京有明，不見不散!